<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107763">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02146963</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A00613-44</org_study_id>
    <nct_id>NCT02146963</nct_id>
  </id_info>
  <brief_title>Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal</brief_title>
  <official_title>Study of the BDNF- Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Esquirol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>INSERM U894</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Esquirol</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is complementary to the main study &quot;Brain Derived Neurotrophic Factor Serum
      Levels Evolution During the Six Months After Alcohol Withdrawal &quot; NCT01491347.

      The purpose of this study is to evaluate the Bdnf gene - Val66Met polymorphism in subjects
      with alcohol dependence according to their alcohol consumption status 6 months after
      withdrawal (relapse or abstinence), in relation to the presence of psychiatric
      co-morbidities.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Frequency of the Bdnf gene Val/Val, Val/Met and Met/Met phenotypes  as a function of relapse</measure>
    <time_frame>at the time of inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum BDNF levels variations between inclusion and 6 months later (or 4 months if the participants does not come for the 4 months-follow-up).</measure>
    <time_frame>6 months after alcohol withdrawal</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>existence of a psychiatric co-morbidity at the inclusion (major depression, schizophrenia, anxiety disorder)</measure>
    <time_frame>at the time of inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence of a psychiatric co-morbidity at 6 months after withdrawal (major depression, schizophrenia, anxiety disorder)</measure>
    <time_frame>6 month after alcohol withdrawal</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>alcohol withdrawal</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        alcohol-dependent subjects hospitalized for alcohol withdrawal
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  participation to the study &quot;BDNF serum levels evolution during 6 months after alcohol
             withdrawal&quot; (main study)

          -  criteria from the main study

        Exclusion Criteria:

          -  criteria from the main study

          -  released or out from the main study before the follow-up at 4 months after withdrawal
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Nubukpo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Esquirol</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe Nubukpo, MD, PhD</last_name>
    <phone>0555431374</phone>
    <email>philippe.nubukpo@ch-esquirol-limoges.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Murielle Girard, PhD</last_name>
    <phone>0555431028</phone>
    <email>murielle.girard@ch-esquirol-limoges.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Esquirol</name>
      <address>
        <city>Limoges</city>
        <zip>87025</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 23, 2014</lastchanged_date>
  <firstreceived_date>May 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Esquirol</investigator_affiliation>
    <investigator_full_name>Philippe Nubukpo</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
